surmount-1 trial tirzepatide weight loss results reduction over time in tirzepatide‐treated participants by Can weight-loss pens really deliver

Hims & Hers Health unveiled a $250 million share repurchase program Tuesday, attempting to signal confidence as its stock faces mounting pressure from intensifying competition in the weight loss drug market

Their therapeutic potential extends beyond metabolic disorders

Vitamin B12 has no tolerable upper intake level, because its potential for toxicity was judged too low to set one

Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders

ALCAR shows to decrease inflammation, which is famous to be a significant contributor to heart disease

An enlarged prostate, also known as BPH or Benign Prostatic Hyperplasia, is a condition in which the prostate enlarges as men get older